Researchers at Purdue University recently discovered a way to disable the part of the SARS virus that makes it invisible to the immune system. The research team investigated the molecular structure of a particular SARS enzyme that strips a host cell of a protein that would normally trigger an immune response to the virus. The researchers may have taken a step toward developing treatments for SARS and other viruses by shutting down that papain-like protease, Science Daily reports. “This is a first step toward creating a weakened and safe virus for use in an attenuated live vaccine,” Andrew Mesecar, the professor of biological sciences and chemistry at Purdue who led the study, said, according to Science Daily. “This also could serve as a molecular roadmap for performing similar studies on other coronaviruses, like MERS, because this enzyme appears to be common to all viruses within this family.” Mesecar and his team are currently...
🔒 Premium Content - For Free
Unlock this content by becoming a Global Health Press subscriber. Join for exclusive articles, expert research, and valuable insights!




